Opko Health
OPK
231 hedge funds and large institutions have $480M invested in Opko Health in 2022 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 63 increasing their positions, 72 reducing their positions, and 24 closing their positions.
33% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 24
1% more funds holding
Funds holding: 229 → 231 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.78% less ownership
Funds ownership: 28.61% → 27.83% (-0.78%)
13% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 72
28% less call options, than puts
Call options by funds: $9.04M | Put options by funds: $12.6M
28% less capital invested
Capital invested by funds: $671M → $480M (-$191M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19M |
| 2 |
Millennium Management
New York
|
+$16.4M |
| 3 |
Renaissance Technologies
New York
|
+$10.1M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.52M |
| 5 |
Citigroup
New York
|
+$5.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$52M |
| 2 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$5.05M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$4.79M |
| 4 |
Rafferty Asset Management
New York
|
-$4.7M |
| 5 |
Morgan Stanley
New York
|
-$3.67M |
OPK Hedge Fund Activity: Q2 2022 in Review
231 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q2 2022, worth a combined $480M — down 28% from $671M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new OPK positions and 24 closed out — a net gain of 8 holders — while 63 added to existing stakes and 72 trimmed.
The largest buyer was Vanguard Group, adding an estimated $19M. The largest seller was State Street, cutting an estimated $52M.
- 231 institutional investors held Opko Health (OPK) as of Q2 2022, up from 229 in Q1 2022.
- Funds reported $480M of Opko Health stock for Q2 2022, down 28% quarter-over-quarter.
- 32 funds opened new Opko Health positions in Q2 2022 and 24 closed out, a net change of +8 holders.
- The largest Opko Health buyer in Q2 2022 was Vanguard Group, an estimated $19M added.
- The largest Opko Health seller in Q2 2022 was State Street, an estimated $52M sold.
Based on aggregated 13F filings for Q2 2022.